Press Releases

09.12.2020

Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial

09.11.2020

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

09.10.2020

Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020

09.09.2020

Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19

09.09.2020

Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

09.08.2020

Biopharma Leaders Unite To Stand With Science

09.03.2020

Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020

08.20.2020

Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19

08.07.2020

Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19

08.06.2020

Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020

08.05.2020

LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer

08.05.2020

Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate